Prognostic Significance of Tumor-associated Stroma in Nasopharyngeal Carcinoma: A Multicenter Study. 2024

Alhadi Almangush, and Miia Ruuskanen, and Jaana Hagström, and Veli-Matti Kosma, and Pentti Nieminen, and Antti A Mäkitie, and Ilmo Leivo
Department of Pathology, University of Helsinki.

Assessment of tumor-associated stroma has shown a reliable prognostic value in recent research. We evaluated the prognostic value of tumor-stroma ratio (TSR) in a large multicenter cohort of nasopharyngeal carcinoma (NPC). We used the conventional hematoxylin and eosin-stained slides of 115 cases of NPC to assess TSR as described in recent guidelines. The amount of tumor-associated stroma was assessed as a percentage and then tumors were classified as stroma-high (>50%) or stroma-low (≤50%). Kaplan-Meier curves, χ 2 test, and Cox regression univariable and multivariable analyses were carried out. A total of 48 (41.7%) tumors were stroma-high and 67 (58.3%) tumors were stroma-low. In the Cox regression multivariable analysis, the tumors categorized as stroma-high were associated with a worse overall survival with a hazard ratio of 2.30 (95% CI: 1.27-4.15, P =0.006) and with poor disease-specific survival (hazard ratio=1.87, 95% CI: 1.07-3.28, P =0.029). The assessment of TSR in NPC is simple and cost-effective, and it has a significant prognostic value. TSR can aid in risk stratification and clinical decision-making in NPC.

UI MeSH Term Description Entries
D009303 Nasopharyngeal Neoplasms Tumors or cancer of the NASOPHARYNX. Cancer of Nasopharynx,Nasopharyngeal Cancer,Cancer of the Nasopharynx,Nasopharynx Cancer,Nasopharynx Neoplasms,Neoplasms, Nasopharyngeal,Cancer, Nasopharyngeal,Cancer, Nasopharynx,Cancers, Nasopharyngeal,Cancers, Nasopharynx,Nasopharyngeal Cancers,Nasopharyngeal Neoplasm,Nasopharynx Cancers,Nasopharynx Neoplasm,Neoplasm, Nasopharyngeal,Neoplasm, Nasopharynx,Neoplasms, Nasopharynx
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077274 Nasopharyngeal Carcinoma A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes. Carcinoma, Nasopharyngeal,Carcinomas, Nasopharyngeal,Nasopharyngeal Carcinomas
D016016 Proportional Hazards Models Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time. Cox Model,Cox Proportional Hazards Model,Hazard Model,Hazards Model,Hazards Models,Models, Proportional Hazards,Proportional Hazard Model,Proportional Hazards Model,Cox Models,Cox Proportional Hazards Models,Hazard Models,Proportional Hazard Models,Hazard Model, Proportional,Hazard Models, Proportional,Hazards Model, Proportional,Hazards Models, Proportional,Model, Cox,Model, Hazard,Model, Hazards,Model, Proportional Hazard,Model, Proportional Hazards,Models, Cox,Models, Hazard,Models, Hazards,Models, Proportional Hazard
D017154 Stromal Cells Connective tissue cells of an organ found in the loose connective tissue. These are most often associated with the uterine mucosa and the ovary as well as the hematopoietic system and elsewhere. Cell, Stromal,Cells, Stromal,Stromal Cell

Related Publications

Alhadi Almangush, and Miia Ruuskanen, and Jaana Hagström, and Veli-Matti Kosma, and Pentti Nieminen, and Antti A Mäkitie, and Ilmo Leivo
October 2012, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Alhadi Almangush, and Miia Ruuskanen, and Jaana Hagström, and Veli-Matti Kosma, and Pentti Nieminen, and Antti A Mäkitie, and Ilmo Leivo
January 2018, Cancer management and research,
Alhadi Almangush, and Miia Ruuskanen, and Jaana Hagström, and Veli-Matti Kosma, and Pentti Nieminen, and Antti A Mäkitie, and Ilmo Leivo
April 2011, Auris, nasus, larynx,
Alhadi Almangush, and Miia Ruuskanen, and Jaana Hagström, and Veli-Matti Kosma, and Pentti Nieminen, and Antti A Mäkitie, and Ilmo Leivo
February 1996, Cancer,
Alhadi Almangush, and Miia Ruuskanen, and Jaana Hagström, and Veli-Matti Kosma, and Pentti Nieminen, and Antti A Mäkitie, and Ilmo Leivo
September 2020, Medicine,
Alhadi Almangush, and Miia Ruuskanen, and Jaana Hagström, and Veli-Matti Kosma, and Pentti Nieminen, and Antti A Mäkitie, and Ilmo Leivo
May 2013, BMC cancer,
Alhadi Almangush, and Miia Ruuskanen, and Jaana Hagström, and Veli-Matti Kosma, and Pentti Nieminen, and Antti A Mäkitie, and Ilmo Leivo
June 2018, International journal of cancer,
Alhadi Almangush, and Miia Ruuskanen, and Jaana Hagström, and Veli-Matti Kosma, and Pentti Nieminen, and Antti A Mäkitie, and Ilmo Leivo
December 2012, Clinical & experimental metastasis,
Alhadi Almangush, and Miia Ruuskanen, and Jaana Hagström, and Veli-Matti Kosma, and Pentti Nieminen, and Antti A Mäkitie, and Ilmo Leivo
May 2004, International journal of radiation oncology, biology, physics,
Alhadi Almangush, and Miia Ruuskanen, and Jaana Hagström, and Veli-Matti Kosma, and Pentti Nieminen, and Antti A Mäkitie, and Ilmo Leivo
January 1995, American journal of otolaryngology,
Copied contents to your clipboard!